Reportlinker Adds Disease and Therapy Review: Asthma

Tuesday, June 29, 2010 General News
Email Print This Page Comment
Font : A-A+



NEW YORK, June 29 Reportlinker.com announces that a new market research report is available in its catalogue:

Disease and Therapy Review: Asthma

http://www.reportlinker.com/p0210877/Disease-and-Therapy-Review-Asthma.html

Abstract

The Asthma Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the asthma market, as well as sales of leading drugs and therapies are provided.

Additional Details

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

Table of contents

1 Overview

Symptoms and severity

2 incidence and prevalence

Incidence Table (US, Italy)

Prevalence Table (US, Canada, Mexico, England, UK, France, Germany, Italy, Spain, China, India, Japan, Turkey, Australia, Worldwide)

3 diagnosis and treatment

Guidelines for diagnosis and management

Long-term medications

Quick-relief medications

Approach to treatment of asthma exacerbations

Treatment rates

4 dosing and treatment costs

5 market size

6 comments

7 References/Resources

To order this report:

Therapy Industry: Disease and Therapy Review: Asthma

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!

CONTACT: Nicolas Bombourg Reportlinker Email: nbo@reportlinker.com US: (805)652-2626 Intl: +1 805-652-2626

SOURCE Reportlinker


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook